90357299 - EXO-TARGET

Information

• Trademark
• 90357299

• Source

• Serial Number

  90357299

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 03, 2020
  4 years ago

• Transaction Date

  November 19, 2024
  14 days ago

• Status Date

  November 19, 2024
  14 days ago

• Published for Opposition Date

  November 19, 2024
  14 days ago

• Location Date

  October 17, 2024
  a month ago

• Status Code

  686

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MCCLELLAN, MATTHEW

• Attorney Docket Number

  TK0172069

  Attorney Name

  Jae Youn Kim

  Law Office Assigned Location Code

  N30

• Owners

  • ILIAS BIOLOGICS INC

Case File Statements

• GS0051: Pharmaceutical preparations for treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; drug delivery agents in the form of capsules, tablets, pills, powders, liquids, suspensions, injection, creams, emulsions, gels, liniments, lotions, ointments, pathes, solutions, syrups, aerosols, granules, implants, inhalants, pellets that facilitate the delivery of pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological preparations in the nature of comprising extracellular vesicles known as exosomes for therapeutic applications; extracellular vesicles for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biochemical drug delivery agent in the form of capsules, tablets, pills, powders, liquids, suspensions, injection, creams, emulsions, gels, liniments, lotions, ointments, pathes, solutions, syrups, aerosols, granules, implants, inhalants, pellets that facilitate the delivery of pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; preparations of microorganisms for medical and veterinary use for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; reagents for use in medical genetic testing; diagnostic reagents for medical use; biological preparations for medical or veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological reagents for clinical medical use
• GS0011: Biological preparations, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; proteins for the food industry; chemical reagents, other than for medical or veterinary purpose
• GS0421: Biotechnology research; technological research in the field of cell biology; laboratory research in the field of cell biology; pharmaceutical drug development services; genetic testing for scientific research purposes; research in the field of chemistry; drug discovery services; medical research and development services; pharmaceutical research and development services; biopharmaceutical research and development services

Case File Event Statements

• 12/7/2020 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/3/2021 - 3 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/9/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/20/2021 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/3/2021 - 3 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/3/2021 - 3 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/3/2021 - 3 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/3/2021 - 3 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/4/2021 - 3 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/1/2024 - 10 months ago

  17 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 1/5/2022 - 2 years ago

  11 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 1/5/2022 - 2 years ago

  12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 1/5/2022 - 2 years ago

  10 - SUSPENSION LETTER WRITTEN Type: CNSL

• 7/18/2022 - 2 years ago

  13 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 10/12/2022 - 2 years ago

  14 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 4/18/2023 - a year ago

  15 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 7/6/2023 - a year ago

  16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 2/26/2024 - 9 months ago

  18 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 2/26/2024 - 9 months ago

  19 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 2/26/2024 - 9 months ago

  20 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 5/26/2024 - 6 months ago

  21 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 6/24/2024 - 5 months ago

  24 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/24/2024 - 5 months ago

  22 - ASSIGNED TO LIE Type: ALIE

• 7/8/2024 - 4 months ago

  25 - FINAL REFUSAL WRITTEN Type: CNFR

• 7/8/2024 - 4 months ago

  26 - FINAL REFUSAL E-MAILED Type: GNFR

• 10/7/2024 - a month ago

  29 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/7/2024 - a month ago

  30 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/7/2024 - a month ago

  28 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 10/11/2024 - a month ago

  31 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/13/2024 - 20 days ago

  32 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/19/2024 - 14 days ago

  33 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/19/2024 - 14 days ago

  34 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/8/2024 - 4 months ago

  27 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 6/24/2024 - 5 months ago

  23 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA